Abilify Maintena and INSOMNIA

1,393 reports of this reaction

1.4% of all Abilify Maintena reports

#17 most reported adverse reaction

Overview

INSOMNIA is the #17 most commonly reported adverse reaction for Abilify Maintena, manufactured by Otsuka America Pharmaceutical, Inc.. There are 1,393 FDA adverse event reports linking Abilify Maintena to INSOMNIA. This represents approximately 1.4% of all 96,636 adverse event reports for this drug.

Patients taking Abilify Maintena who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INSOMNIA1,393 of 96,636 reports

INSOMNIA is a less commonly reported adverse event for Abilify Maintena, but still significant enough to appear in the safety profile.

Other Side Effects of Abilify Maintena

In addition to insomnia, the following adverse reactions have been reported for Abilify Maintena:

DRUG INEFFECTIVE — 4,787 reports
OFF LABEL USE — 3,514 reports
PRODUCT USE IN UNAPPROVED INDICATION — 3,025 reports
WEIGHT INCREASED — 2,605 reports
DRUG INTERACTION — 2,342 reports
ANXIETY — 2,077 reports
CONDITION AGGRAVATED — 1,789 reports
FATIGUE — 1,718 reports
SUICIDE ATTEMPT — 1,653 reports
SUICIDAL IDEATION — 1,574 reports

Other Drugs Associated with INSOMNIA

The following drugs have also been linked to insomnia in FDA adverse event reports:

ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, DIPHENHYDRAMINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE ALPRAZOLAM AMANTADINE AMANTADINE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE ANASTROZOLE

Frequently Asked Questions

Does Abilify Maintena cause INSOMNIA?

INSOMNIA has been reported as an adverse event in 1,393 FDA reports for Abilify Maintena. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INSOMNIA with Abilify Maintena?

INSOMNIA accounts for approximately 1.4% of all adverse event reports for Abilify Maintena, making it a notable side effect.

What should I do if I experience INSOMNIA while taking Abilify Maintena?

If you experience insomnia while taking Abilify Maintena, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Abilify Maintena Full Profile All Drugs Causing INSOMNIA Otsuka America Pharmaceutical, Inc. Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.